These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36257368)

  • 41. Microtubule-associated protein/microtubule affinity-regulating kinase 4 (MARK4) plays a role in cell cycle progression and cytoskeletal dynamics.
    Rovina D; Fontana L; Monti L; Novielli C; Panini N; Sirchia SM; Erba E; Magnani I; Larizza L
    Eur J Cell Biol; 2014; 93(8-9):355-65. PubMed ID: 25123532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies.
    Lund H; Gustafsson E; Svensson A; Nilsson M; Berg M; Sunnemark D; von Euler G
    Acta Neuropathol Commun; 2014 Feb; 2():22. PubMed ID: 24533944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism.
    Li X; Thome S; Ma X; Amrute-Nayak M; Finigan A; Kitt L; Masters L; James JR; Shi Y; Meng G; Mallat Z
    Nat Commun; 2017 Jun; 8():15986. PubMed ID: 28656979
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.
    Ahmed S; Queen A; Irfan I; Siddiqui MN; Abdulhameed Almuqdadi HT; Setia N; Ansari J; Hussain A; Hassan MI; Abid M
    ACS Omega; 2024 Jun; 9(24):25945-25959. PubMed ID: 38911744
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.
    Drewes G; Trinczek B; Illenberger S; Biernat J; Schmitt-Ulms G; Meyer HE; Mandelkow EM; Mandelkow E
    J Biol Chem; 1995 Mar; 270(13):7679-88. PubMed ID: 7706316
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Ahmed Atto Al-Shuaeeb R; Abd El-Mageed HR; Ahmed S; Mohamed HS; Hamza ZS; Rafi MO; Ahmad I; Patel H
    J Biomol Struct Dyn; 2023; 41(23):14484-14496. PubMed ID: 37184133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microtubule affinity-regulating kinase 4: structure, function, and regulation.
    Naz F; Anjum F; Islam A; Ahmad F; Hassan MI
    Cell Biochem Biophys; 2013 Nov; 67(2):485-99. PubMed ID: 23471664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of glioblastoma multiforme associated mutations on the structure and function of MAP/microtubule affinity regulating kinase 4.
    Naqvi AAT; Jairajpuri DS; Hussain A; Hasan GM; Alajmi MF; Hassan MI
    J Biomol Struct Dyn; 2021 Mar; 39(5):1781-1794. PubMed ID: 32141394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gain-of-function MARK4 variant associates with pediatric neurodevelopmental disorder and dysmorphism.
    Samra S; Sharma M; Vaseghi-Shanjani M; Del Bel KL; Byres L; Lin S; Dalmann J; Salman A; Mwenifumbo J; Modi BP; Biggs CM; Boelman C; Clarke LA; Lehman A; Turvey SE
    HGG Adv; 2024 Jan; 5(1):100259. PubMed ID: 38041405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy.
    Peerzada MN; Khan P; Khan NS; Avecilla F; Siddiqui SM; Hassan MI; Azam A
    ACS Omega; 2020 Sep; 5(36):22759-22771. PubMed ID: 32954123
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors.
    Khan NS; Khan P; Inam A; Ahmad K; Yousuf M; Islam A; Ali S; Azam A; Husain M; Hassan MI
    RSC Adv; 2020 May; 10(34):20129-20137. PubMed ID: 35520423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
    Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
    Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro.
    Naz F; Islam A; Ahmad F; Hassan MI
    Mol Cell Biochem; 2015 Dec; 410(1-2):223-8. PubMed ID: 26346160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ubiquitin-associated domain of MARK4 provides stability at physiological pH.
    Naz F; Sami N; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2016 Dec; 93(Pt A):1147-1154. PubMed ID: 27677563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microtubule affinity regulating kinase 4: A promising target in the pathogenesis of atherosclerosis.
    Qin YS; Li H; Wang SZ; Wang ZB; Tang CK
    J Cell Physiol; 2022 Jan; 237(1):86-97. PubMed ID: 34289095
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Sultanakhmetov G; Limlingan SJM; Fukuchi A; Tsuda K; Suzuki H; Kato I; Saito T; Weitemier AZ; Ando K
    Brain Commun; 2024; 6(3):fcae136. PubMed ID: 38712317
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of potential neuroprotective compound from
    Ahmad F; Singh G; Soni H; Tandon S
    Aging Med (Milton); 2023 Jun; 6(2):144-154. PubMed ID: 37287673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy.
    Anwar S; Mohammad T; Shamsi A; Queen A; Parveen S; Luqman S; Hasan GM; Alamry KA; Azum N; Asiri AM; Hassan MI
    Biomedicines; 2020 May; 8(5):. PubMed ID: 32422877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.
    Fontana L; Rovina D; Novielli C; Maffioli E; Tedeschi G; Magnani I; Larizza L
    Cancer Lett; 2015 Apr; 359(1):87-96. PubMed ID: 25578778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MARK4 protein can explore the active-like conformations in its non-phosphorylated state.
    Ahrari S; Khosravi F; Osouli A; Sakhteman A; Nematollahi A; Ghasemi Y; Savardashtaki A
    Sci Rep; 2019 Sep; 9(1):12967. PubMed ID: 31506531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.